Senate Committee on Health and Human Services

  • Twitter
  • Facebook
  • Google+
  • Linkedin
This report consists of 2 parts. The first section is data provided as of May 4th and the second section is data provided as of May 8th. This report will be updated on a regular basis going forward.   The data provided below is presented as of May 4th 2023; 5:00 pm March 8th, 2023 The committee considered organizational issues, adoption of the rules, and the following business: SB 241         Perry     Engrossed Bill sent to House Public Health; Reported Favorably without amendment; Companion: HB 2529 by Talarico, Identical Relating to written notification provided by drug manufacturers regarding the cause of generic insulin prescription drug unavailability. Texas has a compelling interest in protecting the health of its residents. Nearly 3 million people in Texas have diabetes. The price of insulin has increased significantly over the last several decades and there is still no biosimilar or generic version. Despite

Subscribe to gain full access to all of our must-have reports and videos


Log in